NASDAQ:ISPC iSpecimen (ISPC) Stock Price, News & Analysis → Hurry! Buy this stock before the Robinhood traders do! (From Traders Agency) (Ad) Free ISPC Stock Alerts $0.37 -0.03 (-7.50%) (As of 06/10/2024 ET) Add Compare Share Share Today's Range$0.30▼$0.4050-Day Range$0.21▼$0.4352-Week Range$0.20▼$1.75Volume4.61 million shsAverage Volume8.27 million shsMarket Capitalization$3.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get iSpecimen alerts: Email Address Ad Traders AgencyHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades About iSpecimen Stock (NASDAQ:ISPC)iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.Read More ISPC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ISPC Stock News HeadlinesMay 13, 2024 | finance.yahoo.comiSpecimen Inc. (NASDAQ:ISPC) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finance.yahoo.comiSpecimen First Quarter 2024 Earnings: Misses ExpectationsMay 8, 2024 | finance.yahoo.comiSpecimen Inc (ISPC) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...May 7, 2024 | finanznachrichten.deiSpecimen Inc: iSpecimen Reports First Quarter 2024 ResultsMay 7, 2024 | msn.comISPC Stock Earnings: iSpecimen Misses EPS, Misses Revenue for Q1 2024May 7, 2024 | markets.businessinsider.comiSpecimen earnings: here's what to expectMay 7, 2024 | globenewswire.comiSpecimen Reports First Quarter 2024 ResultsApril 25, 2024 | globenewswire.comiSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024April 18, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.06%March 16, 2024 | seekingalpha.comiSpecimen Inc. (ISPC) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | investing.comEarnings call: iSpecimen reports full-year 2023 results, aims for 2024 profitabilityMarch 15, 2024 | sg.finance.yahoo.comNvidia GTC AI conference: What to watchMarch 15, 2024 | finance.yahoo.comiSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comiSpecimen Full Year 2023 Earnings: Misses ExpectationsMarch 14, 2024 | finanznachrichten.deiSpecimen Inc: iSpecimen Reports Full Year 2023 ResultsMarch 14, 2024 | globenewswire.comiSpecimen Reports Full Year 2023 ResultsMarch 13, 2024 | benzinga.comiSpecimen: Q4 Earnings InsightsMarch 13, 2024 | nz.finance.yahoo.comFed rate cuts likely coming after June -strategistMarch 12, 2024 | globenewswire.comiSpecimen Reschedules Full Year 2023 Earnings Release and Conference CallMarch 5, 2024 | globenewswire.comiSpecimen to Report Full Year 2023 Financial Results on March 13, 2024January 23, 2024 | finanznachrichten.deiSpecimen Inc: iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based ResearchJanuary 23, 2024 | markets.businessinsider.comISpecimen, TriMetis Life Sciences Announce Partnership For Tissue ResearchJanuary 23, 2024 | finance.yahoo.comiSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based ResearchJanuary 18, 2024 | finance.yahoo.comiSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024December 21, 2023 | morningstar.comiSpecimen Inc ISPCSee More Headlines Receive ISPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today6/10/2024Next Earnings (Estimated)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:ISPC CUSIPN/A CIK1558569 Webispecimen.com Phone781-301-6700FaxN/AEmployees53Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,100,000.00 Net Margins-124.84% Pretax Margin-124.83% Return on Equity-105.25% Return on Assets-74.41% Debt Debt-to-Equity RatioN/A Current Ratio0.93 Quick Ratio0.93 Sales & Book Value Annual Sales$9.93 million Price / Sales0.37 Cash FlowN/A Price / Cash FlowN/A Book Value$1.07 per share Price / Book0.35Miscellaneous Outstanding Shares9,980,000Free Float6,716,000Market Cap$3.69 million OptionableNot Optionable Beta1.68 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Tracy Wilson Curley (Age 62)CEO, CFO, Treasurer & Director Comp: $437.5kMr. Benjamin Bielak (Age 54)Chief Information Officer & Secretary Comp: $391.2kMs. Carly LejnieksVice President of MarketingMs. Annette ArnoldVice President of Sales & Business DevelopmentMr. David Wages M.D.Ph.D., Chief Medical OfficerMr. Eric LangloisChief Revenue OfficerMr. Evan CoxSenior Vice President of Strategy & InnovationMore ExecutivesKey CompetitorsAIkido PharmaNASDAQ:AIKIData Knights AcquisitionNASDAQ:DKDCAFOXO TechnologiesNYSE:FOXOSeaChange InternationalNASDAQ:SEACCLPS IncorporationNASDAQ:CLPSView All CompetitorsInsidersBenjamin BielakBought 18,000 shares on 9/14/2023Total: $12,960.00 ($0.72/share)View All Insider Transactions ISPC Stock Analysis - Frequently Asked Questions How have ISPC shares performed in 2024? iSpecimen's stock was trading at $0.5006 at the beginning of the year. Since then, ISPC shares have decreased by 26.1% and is now trading at $0.37. View the best growth stocks for 2024 here. When is iSpecimen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024. View our ISPC earnings forecast. How were iSpecimen's earnings last quarter? iSpecimen Inc. (NASDAQ:ISPC) issued its earnings results on Tuesday, May, 7th. The company reported ($0.32) earnings per share (EPS) for the quarter. The company had revenue of $2.29 million for the quarter. iSpecimen had a negative trailing twelve-month return on equity of 105.25% and a negative net margin of 124.84%. When did iSpecimen IPO? iSpecimen (ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO. How do I buy shares of iSpecimen? Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ISPC) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.